Breast Cancer

Bringing together experts in breast cancer diagnosis and treatment from top Chinese hospitals, providing precise and personalized solutions, offering lifelong health management services, and offering a one-stop privileged medical journey to China.

1. Integrated breast-conserving plastic surgery and repair with precise classification and treatment High rate of breast-conserving surgery, integrated plastic and reconstructive surgery, and precise treatment based on breast type. Early-stage breast cancer can be treated with breast-conserving radical mastectomy and breast reconstruction simultaneously, avoiding the trauma of total mastectomy. 2. Advanced minimally invasive surgery to achieve precise breast preservation. For refractory subtypes such as t

1. Integrated breast-conserving plastic surgery and repair with precise classification and treatment

High rate of breast-conserving surgery, integrated plastic and reconstructive surgery, and precise treatment based on breast type. Early-stage breast cancer can be treated with breast-conserving radical mastectomy and breast reconstruction simultaneously, avoiding the trauma of total mastectomy.

2. Advanced minimally invasive surgery to achieve precise breast preservation.

For refractory subtypes such as triple-negative breast cancer and HER2-positive breast cancer, we have extensive experience in combined immunotherapy and targeted therapy. Our recurrence control rate and long-term survival rate are comparable to those of top hospitals in Europe and America, and our treatment efficacy is on par with the world's top standards .

3. Overall costs are significantly lower than in Europe and America, with no hidden fees.

China has widely adopted proton and heavy ion therapy and robotic minimally invasive surgery with no hidden fees, significantly reducing the cost of treating serious illnesses . Under the same conditions, the overall cost is usually only one-third of that in Europe and the United States, or even lower.

4. Zero waiting period, rapid medical intervention to avoid delays in treatment.

In Europe, America, Japan, and South Korea, the waiting time for specialist appointments and surgeries at public hospitals is generally 3-12 months, while private institutions are extremely expensive and still have a waiting period of 1-3 months. China has a well-established international medical channel, and  breast cancer patients who come to China for medical tourism through Trisana Medguide can have an in-person consultation within 3 days and start treatment within 7 days, allowing for early admission and early recovery and preventing delays in treatment .

China's medical services offer top-notch treatment capabilities, while Trisana Medguide provides reliable support for patient arrival. High-quality medical resources require professional service delivery. Choosing to seek medical treatment in China allows you to rely on our top-tier specialized resources, professional medical team, rigorous service processes, fully managed one-stop service, and long-term safety net. This ensures that every patient experiences: less waiting time, fewer detours, precise medical care, worry-free treatment, and efficient recovery, maximizing the technological, time-saving, and cost-effective advantages of cross-border medical care in China.

1. Connect with China's top medical resources to accurately and personalizedly match hospitals and specialists.

We connect you directly with China's top 10 tertiary hospitals and academician-level experts, providing you with accurate expert appointments, surgery schedule bookings, and personalized treatment plans, eliminating detours in your medical journey.

2. Rigorous and traceable service processes ensure precise and efficient medical tourism.

From initial consultation and assessment, visa assistance, and itinerary planning, to in-hospital medical coordination, postoperative rehabilitation management, and long-tail services after returning home, every step is managed with standard operating procedures (SOPs).

3. Assemble an elite service team to provide butler-style, one-on-one care throughout the entire process.

Our team comprises six elite professionals with advanced degrees, including medical masters and doctors, specializing in medical consultation, medical translation, visa assistance, health management, information development, and professional care. We offer customized service plans and provide one-on-one concierge-style care throughout the entire process.

4. Integrated medical tourism one-stop fully managed VIP service

We offer full-service concierge services, including private car service, hotel and apartment booking, medical services such as medical escort and translation, and access to expedited medical care, as well as daily care such as housekeeping and customized meals, making patients and their families feel at home and worry-free throughout the entire process.

0.Why are Fudan University Shanghai Cancer Center, Shanghai First Maternity and Infant Hospital (Shanghai Red House Hospital for Gynecology) recommended as the best choice? Fudan University Shanghai Cancer Center: The Breast Surgery Department (Shao Zhimin/Wu Jiong Team) is the top brand in China for breast cancer and the largest treatment center in Asia. In 2024, it performed 10,690 surgeries (more than 3 times that of MD Anderson). From 2003–2017, the 5-year overall survival rate for newly diagnosed pa

0.Why are Fudan University Shanghai Cancer Center, Shanghai First Maternity and Infant Hospital (Shanghai Red House Hospital for Gynecology) recommended as the best choice?

Fudan University Shanghai Cancer Center:

The Breast Surgery Department (Shao Zhimin/Wu Jiong Team) is the top brand in China for breast cancer and the largest treatment center in Asia. In 2024, it performed 10,690 surgeries (more than 3 times that of MD Anderson). From 2003–2017, the 5-year overall survival rate for newly diagnosed patients was 93.6%, for carcinoma in situ it was 97.9%, for Stage I it was 98%+, and the 10-year survival rate was 83%. Techniques: Breast-conserving surgery + breast reconstruction accounts for over 50% of cases, with nearly 70% of patients under 40 undergoing breast-conserving surgery/reconstruction. The "Platinum Standard" and "Chinese Standard" for triple-negative breast cancer were published in JCO, with a 5-year disease-free survival rate of 86.5%.

A formalized MDT (Multidisciplinary Team) has been in place since 2005. Pathology is ranked first nationally, and radiotherapy is delivered in an all-in-one 30-minute first treatment. For international patients: Dual campuses in Xuhui and Pudong, with an International Medical Center offering English coordination, English translation of medical records, and pre-approval for commercial insurance. There are over 140 Phase I clinical trials, with convenient enrollment for advanced-stage patients, making it a preferred choice for foreign nationals and overseas Chinese.

Shanghai First Maternity and Infant Hospital (Shanghai Red House Hospital for Gynecology):

The Breast Department (Wu Kejin Team) adopts a differentiated approach focused on "women's full life cycle + fertility preservation." While not a high-volume comprehensive cancer center, it has an outstanding reputation for treating breast cancer in young, pregnant, and reproductive-age women. It performs over a thousand breast surgeries annually, with a 5-year breast cancer survival rate of 95.5% and a breast-conserving surgery + reconstruction rate exceeding 40%. Features: It pioneered domestic guidelines for pregnancy-associated breast cancer, fertility preservation in reproductive-age women, and pre-menopausal endocrine management.

The MDT integrates gynecology, reproductive medicine, and genetics, offering ovarian protection, embryo cryopreservation, and integrated implant/autologous reconstruction. It excels in breast-conserving surgery with concealed axillary incisions. For international patients: Dual campuses in Huangpu and Yangpu. While there is no independent international department, the foreign affairs clinic can handle English translated medical records.

It is suitable for young foreign women, those planning pregnancy or pregnant with breast cancer, families with hereditary BRCA mutations, and individuals who prioritize appearance and fertility preservation. Although its capacity for treating purely advanced-stage cases is not as high as Fudan University Shanghai Cancer Center, it offers the best balance of "disease treatment + fertility preservation + breast preservation."

m0:Some representatives of medical experts in breast cancer:

m1:

doctor:

m2:

doctor:

m3:

doctor:

case:97236635160384513

case:97236635160384513